Investor Relations Meeting
-
Online IR meeting (Webex) for institutional investors on May 19, 2026 -
Coverage: company introduction, business status and plans, Q&A
KOSDAQ Filing Information
- Filing: Holding of Investor Relations Conference (IR)
- Company: Vaxcell-Bio Therapeutics (323990)
- Submission: Vaxcell-Bio Therapeutics
- Receipt: 05-18-2026
- Under KRX KOSDAQ Market Division